{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:22:08Z","timestamp":1768422128644,"version":"3.49.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular diseases account for a significant portion of the worldwide mortality rate. This aroused interest among the specialised scientific community, seeking for solutions based on non-clinical and clinical investigations, to shed light onto the physio-pathology of cardiovascular impairment. It is proven challenging managing chronic cardiovascular illnesses like atherosclerosis, arrhythmias, and diverse cardiomyopathies. In certain cases, there is no approved treatment. In other cases, the need for combining therapeutic components, when dealing with co-morbidities, may increase the risk of toxicity-driven cardiovascular impairment. In this case, because the risk of cardiac events correlates with the QT prolongation rates, the QT or QTc interval prolongation has become an important biomarker to access drug-related cardio-toxicity. Several approaches have been found in the current literature, aiming at improving physiological acceptance, i.e., to reduce toxicity. Nanotechnology has increasingly appeared as a promising ally to modulate active substances, preserving cardiovascular function and optimising drug effectiveness, i.e., acting as a cardio-protective mechanism, leveraging the effects of drug-driven cardio-toxicity. In this manuscript, the author combines plant active compounds and nanotechnological strategies, e.g., nano-encapsulation, nano-enzymes, magnetically driven nano-delivery systems, applied in regenerative medicine, and assesses their effects on the cardiovascular system, e.g., as cardio-protective factors, reducing cardio-toxicity. The aim is to propose a new strategy to tackle atherosclerosis initiation and progression, in a drug design that targets ROS-removal and reduces inflammation, using auto-immunity biomarkers to select key atheroma-related signalling cascades. To analyse physiological phenomena related to atherosclerosis initiation and progression, the author proposes both experimental observations and a new haemorheological computational model of arterial constriction. The results of such analysis are used as motivators in the design of the here presented strategy to tackle atheroma. This novel design is based on degradable polyethylene glycol (PEG) superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE).<\/jats:p>","DOI":"10.3389\/fcvm.2024.1125571","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:52:13Z","timestamp":1719928333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel degradable PEG superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE), to treat ROS-driven cardiovascular-diseases, tested in atherosclerosis as a model disease, and hypothesizing autoimmunity as an atheroma's trigger"],"prefix":"10.3389","volume":"11","author":[{"given":"Glaucia C.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/FCVM.2022.912329\/BIBTEX","article-title":"Clinical manifestations, monitoring, and prognosis: a review of cardiotoxicity after antitumor strategy","volume":"9","author":"Huang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/FCVM.2022.813883\/BIBTEX","article-title":"New insights in early detection of anticancer drug-related cardiotoxicity using perfusion and metabolic imaging","volume":"9","author":"Cadour","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/FCVM.2020.594685\/BIBTEX","article-title":"Red blood cell distribution width is a predictive factor of anthracycline-induced cardiotoxicity","volume":"7","author":"Yaegashi","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/FCVM.2021.605993","article-title":"Exercise training preserves myocardial strain and improves exercise tolerance in doxorubicin-induced cardiotoxicity","volume":"8","author":"Gomes-Santos","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/FCVM.2021.587149\/BIBTEX","article-title":"The effects of repeat-dose doxorubicin on cardiovascular functional endpoints and biomarkers in the telemetry-equipped cynomolgus monkey","volume":"8","author":"Engwall","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3389\/FCVM.2022.907266\/BIBTEX","article-title":"Prevention of anthracycline-induced cardiotoxicity: the good and bad of current and alternative therapies","volume":"9","author":"Sangweni","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3389\/FCVM.2022.966261\/BIBTEX","article-title":"Pharmacogenomics in drug-induced cardiotoxicity: current status and the future","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-04659-w","article-title":"Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes","volume":"12","author":"Ulivieri","year":"2022","journal-title":"Sci Reports"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3389\/FCVM.2022.969942\/BIBTEX","article-title":"Cardiovascular adverse events induced by immune checkpoint inhibitors: a real world study from 2018 to 2022","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3389\/FCVM.2022.881446\/BIBTEX","article-title":"QTc dynamics following cardioversion for persistent atrial fibrillation","volume":"9","author":"Younis","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/FCVM.2021.613625\/BIBTEX","article-title":"QT Prolongation in cancer patients","volume":"8","author":"Kim","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3389\/FCVM.2021.756213","article-title":"Association between dynamic change of QT interval and long-term cardiovascular outcomes: a prospective cohort study","volume":"8","author":"Ye","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S43044-020-0042-Y\/TABLES\/3","article-title":"Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection","volume":"72","author":"Ibrahim","year":"2020","journal-title":"Egypt Hear J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3389\/FMED.2022.866454\/BIBTEX","article-title":"Prediction of ventricular arrhythmias by QRS\/QTc\u2014ratio in citalopram or escitalopram intoxication","volume":"9","author":"Dietrichs","year":"2022","journal-title":"Front Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/S13181-021-00857-0","article-title":"The QT interval and predicting risk in toxicology","volume":"17","author":"Berling","year":"2021","journal-title":"J Med Toxicol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/S11606-019-05477-7\/TABLES\/4","article-title":"Measurement and management of QT interval prolongation for general physicians","volume":"35","author":"Indraratna","year":"2020","journal-title":"J Gen Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/bjc.2015.82","article-title":"Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors","volume":"112","author":"Kloth","year":"2015","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40360-016-0053-1","article-title":"Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect\u2014comprehensive overview of clinical trials","volume":"17","author":"Wi\u015bniowska","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/978-981-15-1761-7_24","article-title":"Governing issues in nanoscale systems and their potential for improving the therapeutic application of phytoconstituents","author":"Pereira","year":"2020","journal-title":"Plant-derived Bioactives: Production, Properties and Therapeutic Applications"},{"key":"B20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-981-13-7438-8_3","article-title":"Application of biotechnology in producing plant bio-active compounds","volume-title":"Natural Bio-Active Compounds","author":"Pereira","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-0716-2716-7_10\/COVER","article-title":"Novel nanotechnology-driven prototypes for AI-enriched implanted prosthetics following organ failure","volume":"2575","author":"Pereira","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-0716-2716-7_3\/COVER","article-title":"Nanotechnology-driven delivery systems in inoculation therapies","volume":"2575","author":"Pereira","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-0716-2716-7_2\/COVER","article-title":"Latest trends in nucleic Acids\u2019 engineering techniques applied to precision medicine","volume":"2575","author":"Pereira","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-0716-2716-7_15\/COVER","article-title":"The use of 99mTc-labeled stem cells for evaluation of chronic kidney disease","volume":"2575","author":"Gutfilen","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-0716-2716-7_9\/COVER","article-title":"A review of stem cell technology targeting hepatocyte growth as an alternative to organ transplantation","volume":"2575","author":"Goulart","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-0716-2716-7_7\/COVER","article-title":"Advances in regenerative medicine and biomaterials","volume":"2575","author":"\u015eeker","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/FBIOE.2019.00113","article-title":"Use of nanoparticles in tissue engineering and regenerative medicine","volume":"7","author":"Fathi-Achachelouei","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/FBIOE.2021.597958\/BIBTEX","article-title":"Modern world applications for nano-bio materials: tissue engineering and COVID-19","volume":"9","author":"Melchor-Mart\u00ednez","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-0716-2716-7_6\/COVER","article-title":"Assessing the challenges of nanotechnology-driven targeted therapies: development of magnetically directed vectors for targeted cancer therapies and beyond","volume":"2575","author":"Bryan","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-0716-2716-7_12\/COVER","article-title":"Design of SaCas9-HF for in vivo gene therapy","volume":"2575","author":"Tiwari","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/FPHAR.2021.612692\/BIBTEX","article-title":"Nano-neurotheranostics: impact of nanoparticles on neural dysfunctions and strategies to reduce toxicity for improved efficacy","volume":"12","author":"Vinod","year":"2021","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3389\/FBIOE.2022.1024871\/BIBTEX","article-title":"Emerging applications of nanotechnology in context to immunology: a comprehensive review","volume":"10","author":"Mobeen","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3389\/FPHAR.2021.612659\/BIBTEX","article-title":"Novel methods and approaches for safety evaluation of nanoparticle formulations: a focus towards in vitro models and adverse outcome pathways","volume":"12","author":"Tirumala","year":"2021","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/FBIOE.2021.721581\/BIBTEX","article-title":"Regulation of stem cell differentiation by inorganic nanomaterials: recent advances in regenerative medicine","volume":"9","author":"He","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.3389\/FPHAR.2022.999404\/BIBTEX","article-title":"Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/FBIOE.2021.686684\/BIBTEX","article-title":"Advances in nanomaterials for injured heart repair","volume":"9","author":"Guo","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3389\/FCVM.2022.904738\/BIBTEX","article-title":"Editorial: the analysis of nanovesicles, biomaterials and chemical compounds: assisting the promotion of angiogenesis and enhancing tissue engineering strategies","volume":"9","author":"Lionetti","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/FPHAR.2021.640182\/BIBTEX","article-title":"Nano-medicine in the cardiovascular system","volume":"12","author":"Pretorius","year":"2021","journal-title":"Front Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/FBIOE.2021.672594\/BIBTEX","article-title":"Emerging nanotechnology for treatment of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"9","author":"Li","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/FCVM.2021.690533","article-title":"Nanomedicine in oncocardiology: contribution and perspectives of preclinical studies","volume":"8","author":"Borges","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-0716-2716-7_17","article-title":"An automated strategy to handle antigenic variability in immunisation protocols, part II: in vitro transcribed mRNA vector design for inoculation against infectious agent variants","volume":"2575","author":"Pereira","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B42","first-page":"305","article-title":"An automated strategy to handle antigenic variability in immunisation protocols, part I: nanopore sequencing of infectious agent variants","volume-title":"Methods Mol Biol","author":"Pereira","year":"2023"},{"key":"B43","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/978-3-319-53880-8_12","article-title":"A multiscale haemorheological computer-based model of chronic inflammation: an in-depth investigation of erythrocytes-driven flow characteristics in atheroma development\u2014the application of the ThreeIB method","author":"Pereira","year":"2017","journal-title":"Biotechnology and Production of Anti-Cancer Compounds"},{"key":"B45","doi-asserted-by":"publisher","first-page":"508a","DOI":"10.1016\/j.bpj.2012.11.2808","article-title":"An iterative incompressible immersed boundary method applied to biofluid-structure interaction problems","volume":"104","author":"Pereira","year":"2013","journal-title":"Biophys J"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2475-7586.1000117","article-title":"A Multi-layer non-newtonian model of cardiovascular inflammation","volume":"1","author":"Pereira","year":"2016","journal-title":"J Biomed Eng Med Devic"},{"key":"B47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4172\/2475-7586.1000117","article-title":"A multi-layer non-newtonian model of cardiovascular inflammation","volume":"1","author":"Pereira","year":"2016","journal-title":"J Biomed Eng Med Devic"},{"key":"B48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-981-15-2361-8_4","article-title":"Polyphenols role in autoimmune and chronic inflammatory diseases and the advent of computer-driven plant therapies","volume-title":"Plant-derived Bioactives - Chemistry and Mode of Action","author":"Pereira","year":"2020"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/cddis.2011.134","article-title":"DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway","volume":"3","author":"Kang","year":"2012","journal-title":"Cell Death Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s13738-022-02706-5","article-title":"A new nano-delivery system for cisplatin using green-synthesized iron oxide nanoparticles","volume":"20","author":"Poodat","year":"2023","journal-title":"J Iran Chem Soc"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0838-8_7","article-title":"Magnetic nanoparticles as delivery systems to penetrate the blood-brain barrier","author":"Estelrich","year":"","journal-title":"Nanomedicines for Brain Drug Delivery"},{"key":"B52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13204-013-0216-y","article-title":"Magnetic nanoparticle drug delivery systems for targeting tumor","volume":"4","author":"Mody","year":"2014","journal-title":"Appl Nanosci"},{"key":"B53","first-page":"852","article-title":"Captopril-loaded superparamagnetic nanoparticles as a new dual-mode contrast agent for simultaneous in vitro\/in vivo mr imaging and drug delivery system","volume-title":"Pharm Chem J","author":"Pour","year":"2018"},{"key":"B54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1517\/17425247.2013.747507","article-title":"Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics","volume":"10","author":"Mok","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s12274-017-1444-3","article-title":"Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma","volume":"10","author":"Depalo","year":"2017","journal-title":"Nano Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11051-020-04932-5","article-title":"Superparamagnetic graphene oxide\/magnetite nanocomposite delivery system for doxorubicin-induced distinguished tumor cell cycle arrest and apoptosis","volume":"22","author":"Salem","year":"2020","journal-title":"J Nanopart Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnut.2017.00063","article-title":"Taheebo polyphenols attenuate free fatty acid-induced inflammation in murine and human macrophage cell lines as inhibitor of cyclooxygenase-2","volume":"4","author":"Ma","year":"2017","journal-title":"Front Nutr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/01635581.2017.1367940","article-title":"The impact of dietary polyphenols on COX-2 expression in colorectal cancer","volume":"69","author":"Owczarek","year":"2017","journal-title":"Nutr Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/FNAGI.2021.729949\/BIBTEX","article-title":"Potential of sorghum polyphenols to prevent and treat Alzheimer\u2019s disease: a review article","volume":"13","author":"Rezaee","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/1742-2094-10-15","article-title":"Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells","volume":"10","author":"Chuang","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1002\/9780470988558","volume-title":"Plant Secondary Metabolites\u202f: Occurrence, Structure and Role in the Human Diet","author":"Crozier","year":"2006"},{"key":"B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-7205-6_1","article-title":"Secondary metabolites from rosemary (Rosmarinus officinalis L.): structure, biochemistry and therapeutic implications against neurodegenerative diseases","volume-title":"Natural Bio-Active Compounds","author":"Alvi","year":"2019"},{"key":"B63","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/10412905.2021.1936667","article-title":"New insights into the biotechnology and therapeutic potential of Lippia alba (Mill.) N.E.Br. ex P. Wilson","volume":"33","author":"Malik","year":"2021","journal-title":"J Essent Oil Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/FPHAR.2020.00403\/BIBTEX","article-title":"Medicinal plants as a potential and successful treatment option in the context of atherosclerosis","volume":"11","author":"Kirichenko","year":"2020","journal-title":"Front Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/FPHAR.2022.806470\/BIBTEX","article-title":"Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action","volume":"13","author":"Rudrapal","year":"2022","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.3389\/FPHAR.2022.998944\/BIBTEX","article-title":"Natural drugs targeting inflammation pathways can be used to treat atherosclerosis","volume":"13","author":"Song","year":"2022","journal-title":"Front Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/FCVM.2021.697272\/BIBTEX","article-title":"Taurisolo\u00ae, a grape pomace polyphenol nutraceutical reducing the levels of serum biomarkers associated with atherosclerosis","volume":"8","author":"Annunziata","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3389\/FMOLB.2021.832022\/BIBTEX","article-title":"Nanoliposome-encapsulated and non-encapsulated phenolics from achillea millefolium and their biological function in mice challenged by campylobacter jejuni: a comparative study","volume":"8","author":"Nateghi","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1517\/13543784.12.11.1855","article-title":"Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth","volume":"12","author":"Doggrell","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/IJMS18061260","article-title":"The therapeutic potential of anti-inflammatory exerkines in the treatment of atherosclerosis","volume":"18","author":"Yu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/J.ACTBIO.2017.05.029","article-title":"Athero-inflammatory nanotherapeutics: ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation","volume":"57","author":"Chmielowski","year":"2017","journal-title":"Acta Biomater"},{"key":"B72","doi-asserted-by":"publisher","first-page":"740607","DOI":"10.3389\/fchem.2021.740607","article-title":"Nanozymes regulate redox homeostasis in ros-related inflammation","volume":"9","author":"Li","year":"2021","journal-title":"Front Chem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1021\/acs.nanolett.9b05035","article-title":"Ultrasmall rhodium nanozyme with RONS scavenging and photothermal activities for anti-inflammation and antitumor theranostics of colon diseases","volume":"20","author":"Miao","year":"2020","journal-title":"Nano Lett"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1039\/C8TB00022K","article-title":"Novel iron oxide\u2013cerium oxide core\u2013shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases","volume":"6","author":"Wu","year":"2018","journal-title":"J Mater Chem B"},{"key":"B75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.colsurfb.2017.07.081","article-title":"Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers","volume":"159","author":"Bizeau","year":"2017","journal-title":"Colloids Surf B"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1021\/acsbiomaterials.2c00985","article-title":"Glucose oxidase-integrated metal-polyphenolic network as a microenvironment-activated cascade nanozyme for hyperglycemic wound disinfection","volume":"8","author":"Shi","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12951-022-01653-W\/FIGURES\/8","article-title":"Tannin coordinated nanozyme composite-based hybrid hydrogel eye drops for prophylactic treatment of multidrug-resistant Pseudomonas aeruginosa keratitis","volume":"20","author":"Wang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1906024","DOI":"10.1002\/adma.201906024","article-title":"A metal-polyphenol-coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy","volume":"32","author":"Ren","year":"2020","journal-title":"Adv Mater"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1104\/PP.113.228593","article-title":"Novel roles for the polyphenol oxidase enzyme in secondary metabolism and the regulation of cell death in walnut","volume":"164","author":"Araji","year":"2014","journal-title":"Plant Physiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/ACSCENTSCI.1C00866\/ASSET\/IMAGES\/LARGE\/OC1C00866_0008.JPEG","article-title":"Fe-curcumin nanozyme-mediated reactive oxygen Species scavenging and anti-inflammation for acute lung injury","volume":"8","author":"Yuan","year":"2022","journal-title":"ACS Cent Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1039\/d0mh00193g","article-title":"Ultra-small natural product based coordination polymer nanodots for acute kidney injury relief","volume":"8","author":"Zhang","year":"2021","journal-title":"Mater Horiz"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1125571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T14:58:16Z","timestamp":1722437896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1125571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":82,"alternative-id":["10.3389\/fcvm.2024.1125571"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1125571","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"article-number":"1125571"}}